U.S. Supreme Court Weighs Bayer’s Bid to End Roundup Cancer Lawsuits

The U.S. Supreme Court is set to hear arguments on Bayer AG’s attempt to block thousands of lawsuits alleging that its Roundup weedkiller causes cancer. The case centers on a $1.25 million Missouri jury verdict awarded to John Durnell, who claimed he developed non-Hodgkin lymphoma after long-term exposure to glyphosate, the herbicide’s active ingredient. Bayer argues that federal pesticide regulations should override such state-level claims.

At the heart of the dispute is the Federal Insecticide Fungicide and Rodenticide Act (FIFRA), which governs pesticide labeling and prohibits inconsistent state requirements. Bayer maintains that because the U.S. Environmental Protection Agency has repeatedly approved Roundup’s labeling without a cancer warning, failure-to-warn lawsuits should not proceed. However, Durnell’s legal team argues that federal approval does not prevent states from enforcing similar safety standards.

The case carries massive implications, with more than 100,000 lawsuits filed against Bayer following its 2018 acquisition of Monsanto. Facing billions in potential liability, Bayer has proposed a $7.25 billion settlement to resolve many claims, though others remain pending. A ruling, expected by June, could significantly shape the future of product liability cases and the balance between federal regulation and state consumer protections.

Pic Courtesy: google/ images are subject to copyright